Synonym |
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (sea bream) |
Species |
Sea bream |
Protein Accession |
Not available |
Purity |
≥ 95% |
Endotoxin Level |
< 1 EU/μg |
Biological Activity |
Not available |
Expression System |
Chemical synthesis |
Fusion Tag |
None |
Predicted Molecular Mass |
Not available |
Formulation |
Lyophilized |
Reconstitution |
Dissolve in sterile water |
Storage & Stability |
Store at -20°C. Stable for up to 6 months. |
FAQ
What is (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (sea bream) and what does it
do?
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (sea bream) is a synthetic analog of the luteinizing
hormone-releasing hormone (LHRH), which plays a crucial role in the reproductive cycle of vertebrates.
In sea bream, as well as in other fish species, LHRH is involved in the regulation of gonadotropin
release, which in turn stimulates gametogenesis and the production of sex steroids. This analog is
specifically designed to mimic the natural hormone's activity, and during scientific research, it has
been shown to possess strong affinity and potent biological effects similar to those of the naturally
occurring LHRH. Introducing this synthetic peptide into aquaculture practices can significantly enhance
reproductive management in sea bream farming by effectively inducing spawning and controlling the timing
of reproduction. This increased control over the reproductive cycle can lead to improved yields and more
efficient fish farming operations.
Another significant aspect of this analog is its potential
application in the development of hormone-based therapies for managing reproduction in fish. By using
such compounds, fishery managers can more precisely direct the reproductive timing and cycles of fish
populations, ensuring the effective and sustainable restocking of fisheries. Moreover, since it is a
highly selective analog, its usage could minimize side effects and provide a higher safety profile
compared to non-specific hormonal treatments. Researchers are also investigating the possibilities of
using this analog in hybridization programs, where controlling mating and ensuring the success of
certain genetic crosses are prioritized.
The peptide's specific configuration inherently boosts
its stability and activity, making it not only an effective option in terms of reproductive induction
but also economically viable because of its sustained action and reduced necessity for frequent dosing.
By altering certain amino acids, such as the substitution of D-Alanine and the addition of the
ethylamide group at the proline position, this analog exhibits enhanced binding to LHRH receptors. These
molecular fine-tunings allow for desirable modifications in receptor interaction and signal transduction
pathways which underpin the reproductive processes. Therefore, the widespread application of
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH across the aquaculture industry stands to offer significant benefits
to breeding programs and could possibly influence future advances in fish farming technology.
How
does (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (sea bream) compare to natural LHRH in terms of
effectiveness?
The comparison between the natural LHRH and the synthetic analog
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (sea bream) largely revolves around their respective effectiveness in
stimulating the reproductive system of sea bream. Natural LHRH works by binding to specific receptors on
the pituitary gland, thereby triggering the release of gonadotropins, which are crucial for stimulating
the development of gametes and the production of sex hormones. In natural conditions, this biofeedback
mechanism assures the gradual maturation and eventual spawning based on the inherent biological cycles
dictated by environmental cues.
However, in commercial aquaculture and scientific research
scenarios, there is often a need for more immediate or controlled solutions to manage breeding cycles.
This is where the synthetic analog gains its competitive advantage. (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH
has been engineered to maintain a higher receptor affinity and increased metabolic stability compared to
the natural hormone. These properties facilitate a more robust and predictable physiological response.
In essence, the analog elicits a more synchronized and sometimes more intense gonadotropin release,
accelerating gamete maturation processes and, subsequently, spawning.
This potency stems from
the analog's specific structural modifications, which enhance its resistance to enzymatic degradation
and its ability to maintain elevated receptor interaction over time. This translates into a significant
reduction in required dosing and more precise timing in hormone therapy applications. Due to these
characteristics, the synthetic analog allows aquaculture practitioners more control over reproductive
events, helping to increase production cycles and achieve better-fertilized egg counts without the
constraints of varying natural hormone levels.
Moreover, the analog's effectiveness has been
shown not only in sea bream but also across other fish species, which solidifies its standing within the
peptide-based treatments used in aquaculture. Therefore, from both economical and biological
perspectives, the (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH provides a substantial advantage, allowing for a
more systematic and potentially less resource-intensive approach to achieving optimal breeding
productivity in fish farming operations.
What are the potential environmental impacts of using
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH in aquaculture?
When considering the potential environmental
impacts of utilizing (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH in aquaculture, it is imperative to evaluate both
direct and indirect effects on ecosystems. This synthetic analog, while designed to mimic natural
hormonal pathways selectively, introduces external peptides into aquatic environments, raising questions
about implications on non-target species, bioaccumulation, and ecological balance.
Directly, its
introduction theoretically poses minimal risk to aquatic ecosystems if containment and administration
practices are strictly followed. The analog is specific for sea bream and related receptor pathways,
which means it shows limited interaction with non-target species. Furthermore, its synthetic structure
is designed for stability in vivo within the sea bream, potentially translating to swift degradation
once released into the environment, thereby reducing the risks of hormone pollution. However, there is
always the consideration that inappropriate handling or accidental escapes could lead to unforeseen
exposures of other marine organisms. Such exposure may disrupt indigenous hormonal functions or alter
reproductive cycles of other species if they share susceptible receptors.
Indirectly, the use of
hormonal analogs like (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH could contribute to ecological imbalance if not
managed correctly. The accelerated breeding and production rates can lead to higher biomass outputs from
aquaculture sites, which, if not sustainably managed, can increase the pressure on local ecosystems. For
instance, nutrient runoff, increased waste, and higher demands on feed resources can contribute to
eutrophication and other negative ecological impacts, if not countered with sustainable
practices.
Therefore, the environmental context of hormone usage in aquaculture demands
comprehensive management strategies that integrate environmental impact assessments, regulations
concerning the handling and application of synthetic hormones, and continuous monitoring of ecological
health indicators. In conclusion, while (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH offers excellent control over
fish reproduction cycles, it must be utilized as part of a broader strategy emphasizing sustainable
aquaculture developments to mitigate any potential adverse environmental outcomes.
Can
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH be used in species other than sea
bream?
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH, while initially studied and applied primarily in sea
bream due to its prominence in commercial aquaculture, holds cross-species potential due to the
conserved nature of the LHRH across numerous fish taxa. This presents promising opportunities in the
broader field of aquaculture where reproduction management through hormonal pathways is applicable
across different species.
The analog's ability to engage LHRH receptors and trigger downstream
reproductive cues has been evaluated in other species, including those within similar taxonomic levels
or possessing compatible receptor profiles. This cross-reactivity is principally due to the universal
aspects of the hormonal pathways driving gametogenesis and spawning across teleost fish. Researchers
have noted effective gonadotropin release and gamete maturation in trials involving several aquaculture
species, such as tilapia and catfish, which further validates the robustness of its bioactivity beyond
just sea bream.
In practice, the application of this analog to other species would depend on
careful calibration and testing of dose-response relationships to ensure effectiveness and safety. Each
species can vary in their sensitivity to hormonal induction due to differences in receptor structure and
density, metabolic rates, and physiology that might affect hormone dynamics. Successful adoption into
other aquaculture processes would require targeted studies to establish precise dosages, timing, and
delivery methods that align with specific species requirements.
Furthermore, exploring its use
beyond fish, in species like amphibians, that share similar LHRH receptors represents an intriguing area
of research. However, significant groundwork in terms of experimental data and ethical considerations
would be necessary before broader applications. The versatility of (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH
across aquaculture points to a broader future scope for its development as a standardized tool in fish
reproduction, potentially enhancing the reproductive management across a wide array of aquacultured
species.
Discuss the ethical considerations surrounding the use of
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH in aquaculture.
The use of (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH in
aquaculture raises several ethical considerations, reflecting on animal welfare, environmental
stewardship, and the socio-economic impacts of biotechnological interventions. Central to this is the
use of hormonal analogs to alter and control natural breeding cycles, which prompts various ethical
debates and necessitates a balanced evaluation of benefits versus potential negative
consequences.
From an animal welfare perspective, the administration of synthetic hormonal
treatments must ensure that fish are not exposed to undue stress or suffering. The process of
hormone-induced spawning, while technologically advanced, must be accompanied by practices that minimize
handling stress and maximize fish welfare. The welfare implications of repetitive hormonal interventions
across generations also raise questions, particularly regarding their long-term physiological impacts on
aquatic species and potential cumulative effects that might manifest over
generations.
Environmental ethics consider the broader ecological and genetic impacts of using
such reproductive technologies. Concerns arise regarding genetic uniformity and loss of natural
reproductive diversity among farmed fish populations, especially when such practices become commonplace
in aquaculture. The potential for accidental releasing of hormone-treated fish into wild populations
could also disrupt local ecosystems or alter the genetic diversity of native stocks, which challenges
principles of environmental sustainability and biodiversity preservation.
Moreover, ethical
considerations extend to socio-economic dimensions, where the implementation of such technologies might
disproportionately benefit certain sectors of the aquaculture industry while sidelining traditional
fishery practices and communities that rely on environmentally conscientious methods. Therefore, there
is an ethical imperative to ensure that the benefits of using (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH are
equitably distributed, and do not contribute to the monopolization of aquaculture by powerful
stakeholders at the expense of small-scale fisheries.
In navigating these ethical landscapes,
multidisciplinary dialogue involving biotechnologists, ethicists, ecologists, and stakeholders is
crucial. Establishing clear guidelines, regulations, and independent monitoring can mitigate potential
ethical violations while promoting responsible use. This ensures that the advantages of using synthetic
hormonal analogs in aquaculture do not overshadow ethical considerations, maintaining the integrity of
both natural ecosystems and farming communities. Pursuing a path of responsible innovation will allow
aquaculture to flourish sustainably, aligned with ethical best practices and global environmental
stewardship.